CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs ...

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a ...

T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged ...

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

(Juan Gartner/Science Photo Library/Getty Images) The human immune system has evolved an incredible ability to fight off ...

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

As high-parameter T-cell profiling becomes increasingly central to translational research and biomarker discovery, there is ...